Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ORKA Oruka Therapeutics Inc

15,72

-3,29 (-17,31%)

11 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Oruka Therapeutics (NASDAQ:ORKA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Oruka Therapeutics Charts.

Oruka Therapeutics (NASDAQ:ORKA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Oruka Therapeutics Charts.

News Oruka Therapeutics Inc

Form 8-K - Current report
Donnerstag 19 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody
Donnerstag 19 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)
Mittwoch 18 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Mittwoch 27 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Freitag 22 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 22 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference
Dienstag 19 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 18 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Oruka Therapeutics Inc News-Artikel

Sunrise Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen